연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1047. Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
Chung HH, Nam BH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, Kang SB.
Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1467-73.
Link
1046. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array.
Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH.
J Korean Med Sci. 2010 Aug;25(8):1152-9.
Link
1045. The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.
Yu J, Lee HJ, Hur K, Kwak MK, Han TS, Kim WH, Song SC, Yanagihara K, Yang HK.
Invest New Drugs. 2010 Jul 29.
Link
1044. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR.
Gastroenterology. 2010 Jul;139(1):213-25.e3.
Link
1043. Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis.
Lee EH, Park SK, Park B, Kim SW, Lee MH, Ahn SH, Son BH, Yoo KY, Kang D; KOHBRA Research Group; Korean Breast Cancer Society.
Breast Cancer Res Treat. 2010 Jul;122(1):11-25.
Link
1042. Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.
Jang JY, Jeon YK, Kim CW.
BMC Cancer. 2010 Jul 23;10:391.
Link
1041. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS, Han KH, Chung HH, Kim JW, Park NH, Song YS, Kang SB.
Eur J Surg Oncol. 2010 Jul;36(7):691-8.
Link
1040. Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.
Kim IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, Lee SH, Han JH, Lee SH, Kim TM, Kim DW, Kim JE, Paek SH, Kim DG, Kim IA, Kim YJ, Kim JH, Park BJ, Jung HW.
J Neurooncol. 2011 Jul;103(3):595-602.
Link
1039. Targeting epidermal growth factor receptor-associated signaling pathways in non-small cell lung cancer cells: implication in radiation response.
Choi EJ, Ryu YK, Kim SY, Wu HG, Kim JS, Kim IH, Kim IA.
Mol Cancer Res. 2010 Jul;8(7):1027-36.
Link
1038. Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers.
Jeon YK, Kim SH, Choi SH, Kim KH, Yoo BC, Ku JL, Park JG.
World J Gastroenterol. 2010 Jul 7;16(25):3153-60.
Link